 Jeffrey Darst
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 4 | 2026 | 941 | 0.750 |
Why?
| | Heart Ventricles | 1 | 2026 | 767 | 0.650 |
Why?
| | Adaptation, Psychological | 1 | 2026 | 736 | 0.630 |
Why?
| | Cardiac Catheterization | 4 | 2019 | 572 | 0.600 |
Why?
| | Infant, Premature, Diseases | 1 | 2019 | 114 | 0.520 |
Why?
| | Parents | 1 | 2026 | 1428 | 0.500 |
Why?
| | Hypertension, Pulmonary | 6 | 2019 | 1977 | 0.450 |
Why?
| | Quality of Life | 1 | 2026 | 3246 | 0.390 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2019 | 437 | 0.390 |
Why?
| | Septal Occluder Device | 1 | 2012 | 37 | 0.360 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2012 | 59 | 0.350 |
Why?
| | Cardiology Service, Hospital | 1 | 2010 | 29 | 0.310 |
Why?
| | Altitude | 2 | 2012 | 470 | 0.300 |
Why?
| | Exercise Tolerance | 1 | 2010 | 289 | 0.270 |
Why?
| | Fontan Procedure | 1 | 2010 | 200 | 0.270 |
Why?
| | Tachycardia, Ectopic Junctional | 1 | 2007 | 5 | 0.260 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2015 | 394 | 0.260 |
Why?
| | Hemodynamics | 4 | 2019 | 1127 | 0.260 |
Why?
| | Hospitals, Pediatric | 1 | 2010 | 571 | 0.240 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2009 | 358 | 0.240 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 742 | 0.240 |
Why?
| | Pulmonary Artery | 3 | 2019 | 1132 | 0.200 |
Why?
| | Heart-Assist Devices | 1 | 2009 | 571 | 0.190 |
Why?
| | Child, Preschool | 8 | 2026 | 12016 | 0.160 |
Why?
| | Infant, Premature | 2 | 2019 | 635 | 0.150 |
Why?
| | Infant | 11 | 2018 | 10194 | 0.150 |
Why?
| | Angiography | 2 | 2016 | 209 | 0.140 |
Why?
| | Echocardiography | 2 | 2019 | 652 | 0.140 |
Why?
| | Adolescent | 9 | 2026 | 22825 | 0.140 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 19 | 0.140 |
Why?
| | Qualitative Research | 1 | 2026 | 1735 | 0.130 |
Why?
| | Treatment Outcome | 7 | 2019 | 11947 | 0.130 |
Why?
| | Administration, Inhalation | 1 | 2019 | 572 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2026 | 1174 | 0.130 |
Why?
| | Vasodilator Agents | 1 | 2019 | 330 | 0.120 |
Why?
| | Child | 9 | 2026 | 22979 | 0.120 |
Why?
| | Risk | 1 | 2019 | 927 | 0.120 |
Why?
| | Scimitar Syndrome | 1 | 2016 | 10 | 0.120 |
Why?
| | Hemoptysis | 1 | 2016 | 35 | 0.120 |
Why?
| | Foreign Bodies | 1 | 2016 | 110 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2019 | 1344 | 0.110 |
Why?
| | Humans | 18 | 2026 | 147293 | 0.110 |
Why?
| | Boston | 2 | 2015 | 93 | 0.100 |
Why?
| | Nitric Oxide | 1 | 2019 | 892 | 0.100 |
Why?
| | Ketamine | 1 | 2015 | 141 | 0.100 |
Why?
| | Decompression, Surgical | 1 | 2015 | 117 | 0.100 |
Why?
| | Heart Atria | 1 | 2015 | 141 | 0.100 |
Why?
| | Male | 12 | 2026 | 73950 | 0.100 |
Why?
| | Infant, Newborn | 4 | 2019 | 6543 | 0.100 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 1 | 2013 | 28 | 0.100 |
Why?
| | Female | 12 | 2026 | 80076 | 0.100 |
Why?
| | Dexmedetomidine | 1 | 2013 | 47 | 0.100 |
Why?
| | Surveys and Questionnaires | 1 | 2026 | 6164 | 0.090 |
Why?
| | Retrospective Studies | 6 | 2019 | 17560 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 754 | 0.090 |
Why?
| | Pulmonary Veno-Occlusive Disease | 1 | 2011 | 11 | 0.090 |
Why?
| | Cryotherapy | 1 | 2011 | 22 | 0.090 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 675 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 341 | 0.080 |
Why?
| | Heart Rate | 2 | 2015 | 860 | 0.080 |
Why?
| | Anaerobic Threshold | 1 | 2010 | 29 | 0.080 |
Why?
| | Angioplasty, Balloon | 1 | 2011 | 97 | 0.080 |
Why?
| | Altitude Sickness | 1 | 2012 | 142 | 0.080 |
Why?
| | Patient Care Management | 1 | 2010 | 56 | 0.080 |
Why?
| | Respiration | 1 | 2010 | 208 | 0.080 |
Why?
| | Critical Pathways | 1 | 2010 | 111 | 0.070 |
Why?
| | Lung | 2 | 2019 | 4141 | 0.070 |
Why?
| | Body Weight | 1 | 2012 | 976 | 0.070 |
Why?
| | Device Removal | 1 | 2009 | 149 | 0.070 |
Why?
| | Program Development | 1 | 2010 | 369 | 0.070 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2008 | 45 | 0.070 |
Why?
| | Oxygen Consumption | 1 | 2010 | 721 | 0.060 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 199 | 0.060 |
Why?
| | Referral and Consultation | 1 | 2012 | 886 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 675 | 0.060 |
Why?
| | Patient Selection | 1 | 2010 | 746 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2010 | 480 | 0.060 |
Why?
| | Recovery of Function | 1 | 2009 | 724 | 0.050 |
Why?
| | Vascular Surgical Procedures | 1 | 2008 | 347 | 0.050 |
Why?
| | Adult | 2 | 2026 | 41405 | 0.050 |
Why?
| | Blood Pressure | 1 | 2010 | 1785 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3660 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2010 | 1598 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2012 | 3022 | 0.040 |
Why?
| | Infliximab | 1 | 2018 | 111 | 0.030 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2018 | 135 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2791 | 0.030 |
Why?
| | Coronary Vessels | 1 | 2018 | 246 | 0.030 |
Why?
| | Fluoroscopy | 1 | 2016 | 180 | 0.030 |
Why?
| | Antirheumatic Agents | 1 | 2018 | 308 | 0.030 |
Why?
| | Pulmonary Alveoli | 1 | 2018 | 389 | 0.030 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 347 | 0.030 |
Why?
| | Cardiac Output | 1 | 2015 | 179 | 0.030 |
Why?
| | Aspirin | 1 | 2018 | 406 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 487 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2015 | 134 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1093 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 997 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1518 | 0.030 |
Why?
| | Analgesics | 1 | 2015 | 231 | 0.020 |
Why?
| | Skin | 1 | 2018 | 759 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 587 | 0.020 |
Why?
| | Prospective Studies | 2 | 2015 | 8164 | 0.020 |
Why?
| | Stents | 1 | 2015 | 570 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2011 | 5476 | 0.020 |
Why?
| | Age of Onset | 1 | 2012 | 568 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3216 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2030 | 0.020 |
Why?
| | Young Adult | 2 | 2016 | 14437 | 0.020 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2008 | 37 | 0.020 |
Why?
| | Ligation | 1 | 2008 | 91 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3448 | 0.020 |
Why?
| | Rare Diseases | 1 | 2008 | 116 | 0.020 |
Why?
| | Echocardiography, Transesophageal | 1 | 2008 | 132 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2012 | 616 | 0.010 |
Why?
| | Cohort Studies | 1 | 2015 | 6099 | 0.010 |
Why?
| | Colorado | 1 | 2012 | 4591 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 3784 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 36821 | 0.010 |
Why?
|
|
Darst's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|